Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Targets US$ 2.8 Billion Milesto
The endoscopic retrograde cholangiopancreatography (ERCP) devices market sales is expected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032 as a result of an increase in cancer incidence worldwide. The market for endoscopic retrograde cholangiopancreatography (ERCP) equipment is anticipated to develop at...